Annexin A1 and Autoimmunity: From Basic Science to Clinical Applications

Area of Science:

• Immunology
• Autoimmunity
• Molecular Biology

Background:

• Annexin A1 is a key regulator of inflammation and immunity.
• Autoantibodies against Annexin A1 are found in systemic lupus erythematosus (SLE).
• The precise role of Annexin A1 in human autoimmune diseases requires further investigation.

Purpose of the Study:

• To review the association between anti-Annexin A1 autoantibodies and SLE manifestations, particularly lupus nephritis.
• To explore potential mechanisms, such as post-translational modifications within neutrophil extracellular traps (NETs), that may render Annexin A1 immunogenic in SLE.

Main Methods:

• Literature review of existing studies on Annexin A1, autoantibodies, and SLE.
• Analysis of data correlating serum Annexin A1 levels with SLE and lupus nephritis.
• Hypothesis formulation regarding Annexin A1 modification in NETs and its role in autoimmunity.

Main Results:

• Elevated serum Annexin A1 levels are observed in SLE patients with renal complications.
• Increased Annexin A1 levels do not correlate with circulating anti-Annexin A1 autoantibodies.
• Post-translational modifications, like citrullination within NETs, are hypothesized to be crucial for Annexin A1 immunogenicity.

Conclusions:

• While Annexin A1 is implicated in SLE, its direct role in autoantibody development is complex.
• Modified Annexin A1 within NETs, particularly citrullinated Annexin A1, presents a plausible mechanism for triggering autoimmunity in SLE.
• Further experimental validation is needed to confirm Annexin A1 modification as a driver of autoimmunity in human diseases.